Regenerative medicine (RM) in pain management provides new hope for not only reducing pain as a symptom but also for modifying the disease processes that underlie the mechanisms of pain, whether it is degenerative or neuropathic in nature. However, there are conspicuous gaps between the current clinical practice and the science/clinical evidence for the application of RM in pain management. This session specifically was designed by internationally recognized experts in basic science, translational science, and clinical practice of RM to bridge these gaps.
Emerging MSC Therapy to Combat Opioid Tolerance
The Science of MSCs and MSC Therapies
The Pivotal Evidence or the Lack of it for Regenerative Medicine in Clinical Practice
- Describe the scientific rationale of RM in pain management.
- Describe the future direction of RM in pain management by presenting emerging and translational research.
- Describe the pivotal evidence of RM for specific clinical indications in pain management in terms of metrics, data, and outcomes.
- Neuromodulation Review 1 (301)
- Neuromodulation Review 2 (305)
- Diagnostic and Prognostic Anesthetic Blocks for Facet, Sacroiliac, and Knee Joint Pain: An Evidence-Based Update (202)
- Frontiers in Denervation for Chronic Pain: Sacroiliac Joint Complex, Knee, Shoulder, and Hip (206)
- Lumbar Facet Block and Radiofrequency Ablation International Consensus Guidelines Part 1 (210)